2012 Series - Free Webinar April 25th!

Protecting Cerebrovascular Function - From Translational Science to Clinical Trials

Wednesday, April 25, 2012, Noon–1:05 p.m.

Presentation Topics: 
  1. Outcomes of Discontinuing Rivaroxaban Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Analysis from the ROCKET AF Trial  
    Presenter: Jonathan P. Piccini, Duke Clinical Res Inst, Duke Univ Medical Ctr, Durham, NC
    View abstract   |   Science News Summary 
  2. Cerebrovascular Autoregulation Impairment is Associated with Elevations in Plasma Glial Fibrillary Acidic Protein During Congenital Heart Surgery  
    Presenter: Ronald B. Easley, Baylor Coll of Med, Houston, TX
    View manuscript   |   Science News Summary
  • Elliott Antman
  • Robert Harrington
  • Robert Bonow
  • John Murkin
  • Jeffrey Weitz 
  • Mark Clay                 
Posted by on Apr 24, 2012 9:32 AM America/Chicago